News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ContraVir Strengthens Its Board Of Directors With The Addition Of Virology Expert, Scientist, And Entrepreneur, Timothy M. Block, Ph.D.


4/23/2014 7:22:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ContraVir Pharmaceuticals, Inc. (OTCBB:CTRV), an emerging biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that Timothy M. Block, Ph.D. has joined the company’s Board of Directors. A renowned researcher and opinion leader in the field of virology, Dr. Block is a professor and founder of the Hepatitis B Foundation. His scientific work centers on the study and treatment of chronic viral infections including hepatitis B and C, and herpes simplex virus. Dr. Block has invented or co-invented several compounds designed to treat liver cancer and viral infection.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES